Day Zero Diagnostics, Inc. is a Boston-based company founded in 2016 that is pioneering a new class of infectious disease diagnostics using whole-genome sequencing and machine learning to address antibiotic resistance.
Subscribe to see Day Zero Diagnostics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Day Zero Diagnostics, Inc. is a biotechnology company headquartered in United States. It has raised at least $48.1M across the 4 funding rounds on record. Its most recent funding round, Series B, raised $16M in September 2023.
At least $48.1M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $16M | — | |
| — | $21M | — | |
| Series A | $8.6M | — | |
| SEC Form D filing | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.